日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

First Reported Human Cases of Urolithin A Renal Calculi

首例报道的人类尿石素A肾结石病例

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2026.106515
Best, Sara L; Gruzdys, Valentinas; White, Mark; Gromadzka, Natalia; Owen, Benjamin; Zhang, Yongbo; Asplin, John R
Human
毒理研究
肾结石
发表日期：2026
文献求助 收藏

Baseline Urinary Calcium and the Efficacy of Thiazide Diuretics for Kidney Stone Prevention

基线尿钙水平与噻嗪类利尿剂预防肾结石的疗效

期刊:Journal of Urology
影响因子:
doi:10.1097/JU.0000000000005042
Hsi, Ryan S; Yan, Phyllis L; Crivelli, Joseph J; Ferraro, Pietro Manuel; Curhan, Gary C; Best, Sarah; Asplin, John R; Shahinian, Vahakn; Hollingsworth, John M
肾结石
毒理研究
发表日期：2026
文献求助 收藏

The Effect of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists on 24-Hour Urine Parameters: A Retrospective Cohort Study

钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽-1受体激动剂对24小时尿液参数的影响：一项回顾性队列研究

期刊:Kidney360
影响因子:3
doi:10.34067/KID.0000000728
Schaub, Jennifer A; Oerline, Mary K; Crivelli, Joseph J; Maalouf, Naim M; Best, Sara L; Asplin, John R; Hollingsworth, John M; Shahinian, Vahakn; Hsi, Ryan S
信号转导
发表日期：2025
文献求助 收藏

Correction to: The Effect of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists on 24-Hour Urine Parameters: A Retrospective Cohort Study

更正：钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽-1受体激动剂对24小时尿液参数的影响：一项回顾性队列研究

期刊:Kidney360
影响因子:3
doi:10.34067/KID.0000000956
Schaub, Jennifer A; Oerline, Mary K; Crivelli, Joseph J; Maalouf, Naim M; Best, Sara L; Asplin, John R; Hollingsworth, John M; Shahinian, Vahakn; Hsi, Ryan S
信号转导
发表日期：2025
文献求助 收藏

Comparison of Thiazide Versus Alkali for Kidney Stone Recurrence Among Individuals With Hypocitraturia and High Urine pH

噻嗪类利尿剂与碱性药物治疗低柠檬酸尿症和高尿pH值患者肾结石复发的比较

期刊:Kidney Medicine
影响因子:
doi:10.1016/j.xkme.2025.101145
Hsi, Ryan S; Oerline, Mary K; Best, Sara L; Crivelli, Joseph J; Asplin, John R; Shahinian, Vahakn; Hollingsworth, John M
肾结石
毒理研究
发表日期：2025
文献求助 收藏

Thiazide Dose, Urine Calcium, and Symptomatic Kidney Stone Events

噻嗪类药物剂量、尿钙和症状性肾结石事件

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2024.28953
Hsi, Ryan S; Yan, Phyllis L; Maalouf, Naim M; Best, Sara L; Asplin, John R; Shahinian, Vahakn; Hollingsworth, John M
肾结石
毒理研究
发表日期：2024
文献求助 收藏

Real-World Effectiveness of Preventive Pharmacological Therapy in Patients With Urolithiasis: A Retrospective Cohort Study

预防性药物治疗在泌尿系结石患者中的真实世界疗效：一项回顾性队列研究

期刊:American Journal of Kidney Diseases
影响因子:8.2
doi:10.1053/j.ajkd.2023.12.015
Hollingsworth, John M; Oerline, Mary K; Hsi, Ryan S; Crivelli, Joseph J; Krampe, Noah; Asplin, John R; Shahinian, Vahakn B
发表日期：2024
文献求助 收藏

First reported magnesium pyrophosphate kidney stone prompts diagnosis of hypophosphatasia

首例报道的焦磷酸镁肾结石促使人们诊断出低磷酸血症。

期刊:Urology Case Reports
影响因子:0.4
doi:10.1016/j.eucr.2024.102791
Araya, Carlos E; Mercer, Erica S; Asplin, John R; Best, Sara L
肾结石
毒理研究
发表日期：2024
文献求助 收藏

Associations between Net Gastrointestinal Alkali Absorption, 24-Hour Urine Lithogenic Factors, and Kidney Stones

胃肠道净碱吸收、24小时尿液致石因子与肾结石之间的关联

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.0000000000000195
Ferraro, Pietro Manuel; Taylor, Eric N; Asplin, John R; Curhan, Gary C
肾结石
毒理研究
发表日期：2023
文献求助 收藏

Potential for Urolithiasis-related Research Using the Novel Medicare-Litholink Database

利用新型Medicare-Litholink数据库开展泌尿系结石相关研究的潜力

期刊:Urology Practice
影响因子:1.7
doi:10.1097/UPJ.0000000000000378
Krampe, Noah A; Oerline, Mary K; Asplin, John R; Hsi, Ryan S; Crivelli, Joseph J; Shahinian, Vahakn B; Hollingsworth, John M
发表日期：2023
文献求助 收藏